REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/14/2026
Back to search
Official data from USPTO
CELYAD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELYAD
ST13
US500000079186151Class
5, 10, 42
Filing
79186151
Registration
5158439
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
03/15/2026
Trademark type
Word
Nice classes
5, 10, 42
Filing date
08/13/2015
Registration date
03/14/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/30/2024
Last transaction
03/15/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Mont-Saint-Guibert, BE
Examiner
MAYER, DAVID COREY
Law office
N30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Celyad Oncology, Soci?t? anonyme
C. A. (pessoa física)
Representatives
Todd A. Denys PORZIO BROMBERG & NEWMAN, P.C.
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cellular pharmaceutical preparations for medical use for oncology and cardio-vascular disease treatment; Surgical implants being cellular pharmaceutical preparations comprising living tissue; Cellular pharmaceutical preparations for medical use for the treatment of tumors and cardio-vascular diseases
Class 10
Surgical and medical instruments for use in the diagnosis and treatment of oncology and cardio-vascular diseases; Catheters; Medical devices being surgical implants comprising naturalnon-living materials
Class 42
Scientific and technological servicesscientific researchanalysis and testing in the field of oncology and cardio-vascular diseases; Research services in the field of cell therapy and medical and surgical instrument
Publications
History of USPTO decisions and trademark events.
51 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/04/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
05/09/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/15/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
03/15/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/13/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/31/2024
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
04/30/2024
71AG
REGISTERED-SEC.71 ACCEPTED
04/30/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/23/2024
ES71
TEAS SECTION 71 RECEIVED
08/31/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/14/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/20/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/07/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/06/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/08/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/17/2017
FIMP
FINAL DISPOSITION PROCESSED
06/16/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/14/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/14/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/27/2016
PUBO
PUBLISHED FOR OPPOSITION
12/27/2016
GPNX
NOTIFICATION PROCESSED BY IB
12/23/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/07/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/07/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/07/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/19/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/18/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
11/16/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/16/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
11/16/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/16/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/08/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/08/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/07/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/07/2016
ALIE
ASSIGNED TO LIE
11/07/2016
NREV
NOTICE OF REVIVAL - MAILED
10/27/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/27/2016
PETG
PETITION TO REVIVE-GRANTED
10/27/2016
PROA
TEAS PETITION TO REVIVE RECEIVED
10/27/2016
RFNT
REFUSAL PROCESSED BY IB
05/14/2016
MAFR
APPLICATION FILING RECEIPT MAILED
04/26/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/25/2016
RFRR
REFUSAL PROCESSED BY MPU
04/25/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/23/2016
CNRT
NON-FINAL ACTION WRITTEN
04/22/2016
DOCK
ASSIGNED TO EXAMINER
04/22/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/22/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/21/2016
Continuous trademark protection
Get notified about every new filing that threatens CELYAD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.